Friday, Mar 28, 2025 · SEC filings
What the smart money revealed on Mar 28
332 insider filings came in. We hid 29 planned (10b5-1) sellers and 220 people whose filings were routine, like grants and tax withholding.
8 insiders at Oncology Institute (STLN) bought $1.61M of stock
Roles: CEO, CFO, COO, Chief Medical Officer, Director. Several insiders buying in the same few days is rare.
3 insiders at Bridgeline Digital (BLIN) bought $661K of stock
Roles: CEO, Director. Several insiders buying in the same few days is rare.
Globalstar (GSAT) Director James Monroe III bought $4.72M
209,546 shares on the open market. Not a grant or an option exercise.
Rezolute (RZLT) CFO Daron Evans bought $57.7K
20,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.
Capitol Federal Financial (CFFN) Director Jeffrey Johnson bought $56.3K
10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.
Hess (HES) CEO John Hess sold $55.6M
Not marked as a planned 10b5-1 sale. Sold 14% of the shares they held directly. Still holds 2.21M shares.
AutoZone (AZO) President and CEO Philip Daniele sold $7.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 163 shares directly.
Globalstar (GSAT) CEO Paul Jacobs sold $4.72M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 14 more real buys
Show 27 more real sales
13F season
Holdings as of Dec 31, 2024 were due Feb 14
80 funds have filed. 58 filed for the quarter before.
Biggest real insider buys, Mar 22–28
Open-market buys by officers and directors, filed in the 7 days up to Mar 28.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.